Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Ikeda

Showing results (171-180 of 193) with videos related to

Pageof 20
Sort By:
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|October 31, 2002
Fifteen cases of encapsulating peritoneal sclerosis related to peritoneal dialysis: a single-center experience in JapanHiroyasu Yamamoto, Masaaki Nakayama, Ryo yamamoto, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|October 31, 2002
High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatmentRyo Yamamoto, Masaaki Nakayama, Toshio Hasegawa, et al.
Internal Medicine (Tokyo, Japan)|September 28, 2022
Persistent SARS-CoV-2 Infection in a Patient with Nephrotic Syndrome under Rituximab Therapy: Successful Treatment with a Combination of Remdesivir and Monoclonal AntibodiesAkihiro Shimizu, Izumi Shirai, Kyohei Ogawa, et al.
CEN Case Reports|November 30, 2023
Active flare of IgA nephropathy during long-term therapy with anti-tumor necrosis factor-α antibody drugs for Crohn's disease: three case reports and literature reviewAkihiro Shimizu, Nobuo Tsuboi, Kotaro Haruhara, et al.
Clinical and Experimental Nephrology|March 23, 2026
Distinct clinicopathological features of IgA nephropathy associated with Crohn's disease: comparison with ulcerative colitis and non-IBD IgA nephropathyAkihiro Shimizu, Nobuo Tsuboi, Saeko Hatanaka, et al.
Journal of Inflammation (London, England)|May 16, 2012
Effect of erythropoietin-stimulating agent on uremic inflammationYuri Tanaka, Nobuhiko Joki, Hiroki Hase, et al.
Clinical and Experimental Nephrology|September 14, 2011
Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patientsFumihiko Koiwa, Daisuke Komukai, Makoto Hirose, et al.
Epidemiology and Infection|March 24, 2026
Effectiveness of Voluntary PCR Testing Against COVID-19 Spread in Japanese Remote IslandsMoto Kimura, Yusuke Asai, Shinya Tsuzuki, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 22, 2015
Possible prevention of dialysis-requiring congestive heart failure by angiotensin-II receptor blockers in non-dialysis Japanese patients with Stage 5 chronic kidney diseaseMasato Ikeda, Masatsugu Nakao, Keita Hirano, et al.
Virus Research|April 14, 2005
Monoclonal antibodies against regions topologically surrounding the homodimeric beta-barrel interface of Epstein-Barr virus nuclear antigen-1Hiroyuki Eda, Yasuyuki Ishii, Maya Obayashi, et al.
Pageof 20

Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|October 31, 2002
Fifteen cases of encapsulating peritoneal sclerosis related to peritoneal dialysis: a single-center experience in JapanHiroyasu Yamamoto, Masaaki Nakayama, Ryo yamamoto, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|October 31, 2002
High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatmentRyo Yamamoto, Masaaki Nakayama, Toshio Hasegawa, et al.
Internal Medicine (Tokyo, Japan)|September 28, 2022
Persistent SARS-CoV-2 Infection in a Patient with Nephrotic Syndrome under Rituximab Therapy: Successful Treatment with a Combination of Remdesivir and Monoclonal AntibodiesAkihiro Shimizu, Izumi Shirai, Kyohei Ogawa, et al.
CEN Case Reports|November 30, 2023
Active flare of IgA nephropathy during long-term therapy with anti-tumor necrosis factor-α antibody drugs for Crohn's disease: three case reports and literature reviewAkihiro Shimizu, Nobuo Tsuboi, Kotaro Haruhara, et al.
Clinical and Experimental Nephrology|March 23, 2026
Distinct clinicopathological features of IgA nephropathy associated with Crohn's disease: comparison with ulcerative colitis and non-IBD IgA nephropathyAkihiro Shimizu, Nobuo Tsuboi, Saeko Hatanaka, et al.
Journal of Inflammation (London, England)|May 16, 2012
Effect of erythropoietin-stimulating agent on uremic inflammationYuri Tanaka, Nobuhiko Joki, Hiroki Hase, et al.
Clinical and Experimental Nephrology|September 14, 2011
Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patientsFumihiko Koiwa, Daisuke Komukai, Makoto Hirose, et al.
Epidemiology and Infection|March 24, 2026
Effectiveness of Voluntary PCR Testing Against COVID-19 Spread in Japanese Remote IslandsMoto Kimura, Yusuke Asai, Shinya Tsuzuki, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 22, 2015
Possible prevention of dialysis-requiring congestive heart failure by angiotensin-II receptor blockers in non-dialysis Japanese patients with Stage 5 chronic kidney diseaseMasato Ikeda, Masatsugu Nakao, Keita Hirano, et al.
Virus Research|April 14, 2005
Monoclonal antibodies against regions topologically surrounding the homodimeric beta-barrel interface of Epstein-Barr virus nuclear antigen-1Hiroyuki Eda, Yasuyuki Ishii, Maya Obayashi, et al.
Pageof 20